We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Study Showed Trastuzumab-DM1 Shrank Tumors in Women Advanced HER2-positive Breast Cancer

News   Dec 14, 2009

 
Study Showed Trastuzumab-DM1 Shrank Tumors in Women Advanced HER2-positive Breast Cancer
 
 
 

RELATED ARTICLES

A Potential Role for Sperm in Repeat Miscarriages

News

In a new study, researchers analyze the potential role that sperm DNA damage may have in recurrent pregnancy loss.

READ MORE

Nanotechnology Approach for Treating Aggressive Breast Cancer

News

Triple negative breast cancer has no currently approved targeted therapies for treatment. Utilizing nanotechnology, a research group have developed a method that targets specific genes in triple negative breast cancer, killing cancerous cells.

READ MORE

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE